Malignant neoplasm of mandible
ICD-10 C41.1 is a billable code used to indicate a diagnosis of malignant neoplasm of mandible.
Malignant neoplasm of the mandible refers to cancerous tumors that arise from the bone tissue of the mandible, which is the lower jawbone. These tumors can be classified as primary bone sarcomas, such as osteosarcoma, chondrosarcoma, or Ewing's sarcoma, or as metastatic lesions from other primary cancers. Imaging characteristics typically include lytic lesions, periosteal reactions, and possible soft tissue masses, which can be evaluated through X-rays, CT scans, and MRIs. Multidisciplinary management is crucial, involving surgical resection, chemotherapy, and radiation therapy, depending on the tumor type and stage. The prognosis varies significantly based on the histological type, size, and presence of metastasis. Early detection and comprehensive treatment planning are essential for improving patient outcomes.
Detailed pathology reports, imaging studies, and treatment plans.
Diagnosis and management of primary bone sarcomas and metastatic lesions.
Accurate staging and grading of tumors are critical for treatment planning.
Surgical reports, imaging studies, and follow-up care documentation.
Surgical resection of mandibular tumors and reconstruction.
Documentation must include the extent of resection and any reconstructive procedures performed.
Used during surgical resection of a malignant neoplasm of the mandible.
Surgical notes detailing the extent of resection and pathology results.
Oral and maxillofacial surgeons must document the surgical approach and any reconstructive efforts.
Imaging studies such as X-rays, CT scans, and MRIs are essential to document the presence and extent of the malignant neoplasm. Detailed imaging reports should be included in the patient's medical record to support the diagnosis.
